The plasma peptides of ovarian cancer

Autor: Jaimie Dufresne, Pete Bowden, Thanusi Thavarajah, Angelique Florentinus-Mefailoski, Zhuo Zhen Chen, Monika Tucholska, Tenzin Norzin, Margaret Truc Ho, Morla Phan, Nargiz Mohamed, Amir Ravandi, Eric Stanton, Arthur S. Slutsky, Claudia C. dos Santos, Alexander Romaschin, John C. Marshall, Christina Addison, Shawn Malone, Daren Heyland, Philip Scheltens, Joep Killestein, Charlotte E. Teunissen, Eleftherios P. Diamandis, K. W. Michael Siu, John G. Marshall

Publikováno v: Clinical Proteomics, Vol 15, Iss 1, Pp 1-19 (2018)

Abstract Background It may be possible to discover new diagnostic or therapeutic peptides or proteins from blood plasma by using liquid chromatography and tandem mass spectrometry to identify, quantify and compare the peptides cleaved ex vivo from di

Externí odkaz: https://doaj.org/article/ba28344035984cfb9422f39d7b01a2db

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The plasma peptides of ovarian cancer

Autor: Shawn Malone, Claudia C. dos Santos, Angelique Florentinus-Mefailoski, John Marshall, Christina L. Addison, Philip Scheltens, Joep Killestein, Morla Phan, Tenzin Norzin, Amir Ravandi, Nargiz Mohamed, Margaret Truc Ho, Eric Stanton, Charlotte E. Teunissen, Jaimie Dufresne, Eleftherios P. Diamandis, Arthur S. Slutsky, K. W. Michael Siu, John C. Marshall, Thanusi Thavarajah, Monika Tucholska, Zhuo Zhen Chen, Daren K. Heyland, Pete Bowden, Alexander D. Romaschin

Publikováno v: Dufresne, J, Bowden, P, Thavarajah, T, Florentinus-Mefailoski, A, Chen, Z Z, Tucholska, M, Norzin, T, Ho, M T, Phan, M, Mohamed, N, Ravandi, A, Stanton, E, Slutsky, A S, Dos Santos, C C, Romaschin, A, Marshall, J C, Addison, C, Malone, S, Heyland, D, Scheltens, P, Killestein, J, Teunissen, C E, Diamandis, E P, Michael Siu, K W & Marshall, J G 2018, ' The plasma peptides of ovarian cancer ', Clinical Proteomics, vol. 15, no. 1, 41 . https://doi.org/10.1186/s12014-018-9215-z
Clinical Proteomics, 15(1):41. BioMed Central Ltd.
Clinical Proteomics, Vol 15, Iss 1, Pp 1-19 (2018)
Clinical Proteomics

Background It may be possible to discover new diagnostic or therapeutic peptides or proteins from blood plasma by using liquid chromatography and tandem mass spectrometry to identify, quantify and compare the peptides cleaved ex vivo from different c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93abfb915fd2e156372e2f0b98977aec
https://doi.org/10.32920/14638320

The plasma peptides of sepsis

Autor: John Marshall, Thanusi Thavarajah, Pete Bowden, Claudia C. dos Santos, Alexander D. Romaschin, Arthur S. Slutsky

Publikováno v: Clinical Proteomics

Background A practical strategy to discover sepsis specific proteins may be to compare the plasma peptides and proteins from patients in the intensive care unit with and without sepsis. The aim was to discover proteins and/or peptides that show great

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f782a13ba27f928e8de89f7762b4a70
https://doi.org/10.1186/s12014-020-09288-5

The plasma peptides of breast versus ovarian cancer

Autor: Morla Phan, Daren K. Heyland, Charlotte E. Teunissen, Thanusi Thavarajah, Eleftherios P. Diamandis, Margaret Truc Ho, Philip Scheltens, Nargiz Mohamed, Eric Stanton, Amir Ravandi, Shawn Malone, John Marshall, Tenzin Norzin, K. W. M. Siu, Zhuo Zhen Chen, Arthur S. Slutsky, Monika Tucholska, Joep Killestein, Claudia C. dos Santos, Jaimie Dufresne, Christina L. Addison, Angelique Florentinus-Mefailoski, Pete Bowden, Alexander D. Romaschin

Publikováno v: Clinical Proteomics, 16(1):43. BioMed Central Ltd.
Clinical Proteomics
Dufresne, J, Bowden, P, Thavarajah, T, Florentinus-Mefailoski, A, Chen, Z Z, Tucholska, M, Norzin, T, Ho, M T, Phan, M, Mohamed, N, Ravandi, A, Stanton, E, Slutsky, A S, Dos Santos, C C, Romaschin, A, Marshall, J C, Addison, C, Malone, S, Heyland, D, Scheltens, P, Killestein, J, Teunissen, C, Diamandis, E P, Siu, K W M & Marshall, J G 2019, ' The plasma peptides of breast versus ovarian cancer ', Clinical Proteomics, vol. 16, no. 1, 43 . https://doi.org/10.1186/s12014-019-9262-0

Background There is a need to demonstrate a proof of principle that proteomics has the capacity to analyze plasma from breast cancer versus other diseases and controls in a multisite clinical trial design. The peptides or proteins that show a high ob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4f37ee81b208d63888d8ff6f2dd2ad
https://research.vumc.nl/en/publications/7a02b7aa-5ccb-4527-82dc-2c8614c40974